主講者

特邀講者

Prof. Won-Gun Koh

Underwood Distinguished Professor, Yonsei University
Professor, Department of Chemical Engineering, Yonsei University
Prof. Won-Gun Koh is an Underwood Distinguished Professor in the Department of Chemical Engineering at Yonsei University. He focuses on various aspects of chemical engineering, including energy storage, nano-materials, and catalysis. Prof. Koh is recognized for his work in advancing the development of new technologies, contributing to both academic research and industry. For more details about his publications, research, and contributions, please refer to the Yonsei University faculty page.

特邀講者

Prof. Youn, Yu Seok

Professor, College of Pharmacy, Sungkyunkwan University
Director, Research Institute of Pharmaceutical Sciences, Sungkyunkwan University
Editorial Board Member, Asian Journal of Pharmaceutical Sciences
Associate Editor, Archives of Pharmacal Research
Prof. Youn, Yu Seok is a professor at the School of Pharmacy, Sungkyunkwan University. His research interests include peptide and protein drug delivery, nanoparticulate drug delivery systems, polymer conjugation for biopharmaceuticals, and inhalation delivery systems. He has been involved in numerous academic and editorial roles, including positions with the Korean-American Pharmaceutical Scientists Association and various pharmaceutical journals. His work contributes to the development of advanced drug delivery systems, particularly for cancer and other diseases. More information can be found on Sungkyunkwan University's website.

特邀講者

Prof. Shaoyi Jiang

Robert S. Langer ’70 Family and Friends Professor, Meinig School of Biomedical Engineering, Cornell University
Shaoyi Jiang joined the Meinig School at Cornell University as the Robert Langer ’70 Family and Friends Professor in June 2020. Previously, he was the Boeing-Roundhill Professor of Engineering in Chemical Engineering and an adjunct professor of Bioengineering at the University of Washington, Seattle.

Jiang is a pioneer in functional zwitterionic materials, providing molecular-level understanding and developing new classes like poly(carboxybetaine) and poly(sulfobetaine). His innovations include capsule-free subcutaneous implants, hematopoietic stem cell expansion, anticoagulant-free artificial lungs, and environmentally benign marine coatings. His work established zwitterionic materials as biocompatible alternatives to poly(ethylene glycol) (PEG), addressing PEG immunogenicity found in COVID-19 vaccines. With over 50 patents, he co-founded ZWI Therapeutics, Taproot Medical, and Imperion Coatings.

At Cornell, his group integrates immunology with biomaterials and drug delivery research. Their focus includes (i) regenerative and precision medicine: developing materials for iPSC and cancer organoid culture, long-term implants, and blood-contacting devices; and (ii) drug delivery: creating low-immunogenic carriers for mRNAs, DNAs, proteins, and small molecules targeting cancer, neurological diseases, and diabetes. Jiang collaborates extensively across Cornell and beyond, advancing biomedical and engineering applications.

 


特邀講者

Jinjun Shi, Ph.D.

Associate Professor of Anaesthesia, Brigham and Women's Hospital, Harvard Medical School

Dr. Jinjun Shi is an Associate Professor of Anaesthesia at Brigham and Women’s Hospital and a leading researcher in nanomedicine and biomaterials. His laboratory focuses on transformative biomedical applications in nanomedicine, biomaterials, RNA therapy, immunotherapy, and antioxidative therapy. Current research areas include: RNAi delivery for gene silencing ; mRNA delivery for protein replacement ; Nanoparticle-mediated immune modulation ; Development of stimuli-responsive nanomaterials and bioinspired antioxidative polymers.

Dr. Shi has received numerous prestigious honors, including the NIH Pathway to Independence Award (K99/R00), Movember-PCF Challenge Award, DoD LCRP Concept Award, and the ALA Lung Cancer Discovery Award. He was elected as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and has been recognized as a Clarivate Highly Cited Researcher from 2022 to 2024.


特邀講者

Prof. Warren Chan

Dean, College of Engineering, Nanyang Technological University
Professor, School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University

Professor, School of Materials Science & Engineering, Nanyang Technological University
Executive Editor, ACS Nano


Dr. Warren Chan is the Dean of the College of Engineering and the President’s Chair Professor in Engineering at Nanyang Technological University (NTU). He received his B.S. degree from the University of Illinois in 1996, Ph.D. from Indiana University in 2001, post-doctoral training at the University of California (San Diego). He started as an Assistant Professor at the University of Toronto from 2002, became Full professor in 2012, and the Canadian Research Chair in Nanoengineering. He was the Director of the Institute of Biomedical Engineering before joining NTU. His lab develops nanotechnology for diagnosing and treating cancer and infectious diseases. He is an Executive Editor of ACS Nano.


特邀講者

Dr. Dean HO 

Head, Department of Biomedical Engineering, National University of Singapore
Provost’s Chair Professor, National University of Singapore

Director, The N.1 Institute for Health (N.1), National University of Singapore
Director, The Institute for Digital Medicine (WisDM), National University of Singapore


Professor Dean Ho is currently Provost’s Chair Professor, Director of The Institute for Digital Medicine (WisDM) at the Yong Loo Lin School of Medicine; Director of The N.1 Institute for Health (N.1), and Head of the Department of Biomedical Engineering at the National University of Singapore.

Prof. Ho and collaborators manage a portfolio of over 10 prospective, interventional human clinical trials. His team successfully developed and validated CURATE.AI, a powerful artificial intelligence platform that personalizes human treatment for a broad spectrum of indications ranging from oncology, to digital therapeutics and infectious diseases, among others.

Prof. Ho is an elected Fellow of the US National Academy of Inventors (NAI), American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), and the Royal Society of Chemistry. He was also named to the HIMSS Future50 Class of 2021 for his internationally-recognised leadership in digital health. Prof. Ho is a Co-Chair of the World Health Organization (WHO) Working Group for the regulation of AI for Health.


特邀講者

Prof. Kanyi Pu

President's Chair Professor in Biomedical Engineering, Nanyang Technological University
Associate Dean (Research), College of Engineering, Nanyang Technological University

Executive Editor, Journal of the American Chemical Society


Dr. Kanyi Pu is a President’s Chair Professor at the School of Chemistry, Chemical Engineering and Biotechnology (CCEB) and Lee Kong Chian School of Medicine at NTU.

He serves as the executive editor for the Journal of the American Chemical Society and acts as an editorial advisory board member for over 18 renowned journals, including Chemical Society Reviews, Advanced Functional Materials, Biomaterials, Small, and Bioconjugate Chemistry.

Additionally, he holds the role of Associate Dean for Research at the College of Engineering. Recognized as one of the world's most influential researchers in Chemistry and Materials Science fields by Web of Science, he has received esteemed awards, including the Singapore National Research Foundation (NRF) Investigatorship and the Biomaterials Science Lectureship Award.